Turkish Journal of Nephrology
Review

Sarcopenia in Patients with Chronic Kidney Disease

1.

Department of Nephrology, Kahramanmaraş Sütçü İmam University Faculty of Medicine, Kahramanmaraş, Turkey

2.

Department of Nephrology, Bahçeşehir University Faculty of Medicine, İstanbul, Turkey

3.

Division of Nephrology, Hypertension and Kidney Transplantation, University of California Irvine School of Medicine, Orange, CA, USA

Turkish J Nephrol 2022; 31: 3-6
DOI: 10.5152/turkjnephrol.2022.21223
Read: 553 Downloads: 206 Published: 02 December 2021

Sarcopenia is defined as a decrease in muscle mass and muscle strength, and its frequency increases with aging. Since different criteria and methods can be used for its definition, its incidence rates vary. Chronic kidney disease (CKD) is a progressive process and many systems may be affected in these patients. Studies also show that CKD can lead to the development of sarcopenia. Many factors are held responsible for the development of sarcopenia in CKD. Age, inflammation, malnutrition, uremic toxins and hormonal imbalance are the most important ones. In this review, general information about sarcopenia and the development of sarcopenia in patients with chronic kidney disease are discussed in the light of the literature.
Cite this article as: Güngör Ö, Güzel FB, Ulu S, Zadeh KK. Sarcopenia in patients with chronic kidney disease. Turk J Nephrol. 2022;31(1):3-6.

Files
EISSN 2667-4440